Search Results - "nancey, stéphane"

Editorial: 5‐ASA in IBD patients on biologics—‘stop or continue’? by Veyrard, Pauline, Nancey, Stéphane, Roblin, Xavier

“…LINKED CONTENT This article is linked to Bernstein et al papers. To view these articles, visit https://doi.org/10.1111/apt.16518 and…”
Get full text

Editorial: anti‐TNF agents against vedolizumab as a second‐line treatment? Not surprising tie game by Roblin, Xavier, Paul, Stéphane, Nancey, Stéphane

“…LINKED CONTENT This article is linked to Rundquist et al papers. To view these articles, visit https://doi.org/10.1111/apt.16193 and…”
Get full text

Comparison of short‐ and long‐term effectiveness between ustekinumab and vedolizumab in patients with Crohn's disease refractory to anti‐tumour necrosis factor therapy by Manlay, Luc, Boschetti, Gilles, Pereira, Bruno, Flourié, Bernard, Dapoigny, Michel, Reymond, Maud, Sollelis, Elisa, Gay, Claire, Boube, Mathilde, Buisson, Anthony, Nancey, Stéphane

“…Summary Background The best option between vedolizumab and ustekinumab after anti‐tumour necrosis factor (TNF) failure remains unclear in Crohn's disease. Aims…”
Get full text

Selective Autophagy Receptors in Antiviral Defense by Viret, Christophe, Duclaux-Loras, Rémi, Nancey, Stéphane, Rozières, Aurore, Faure, Mathias

“…Autophagy ensures the degradation of cytosolic substrates by the lysosomal pathway. Cargoes destined to be eliminated are confined within double-membrane…”
Get full text

A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities by D’Amico, Ferdinando, Nancey, Stéphane, Danese, Silvio, Peyrin-Biroulet, Laurent

“…Abstract Background and Aims Faecal calprotectin [FC] is a valid and non-invasive marker of mucosal inflammation. It is widely used both in clinical trials and…”
Get full text

Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial by Roblin, Xavier, Williet, Nicolas, Boschetti, Gilles, Phelip, Jean-Marc, Del Tedesco, Emilie, Berger, Anne-Emmanuelle, Vedrines, Philippe, Duru, Gerard, Peyrin-Biroulet, Laurent, Nancey, Stéphane, Flourie, Bernard, Paul, Stephane

“…In patients with IBD experiencing an immune-mediated loss of response (LOR) to antitumour necrosis factor (anti-TNF), algorithms recommend a switch of anti-TNF…”
Get more information

Use of imaging modalities for decision-making in inflammatory bowel disease by Nancey, Stéphane, Fumery, Mathurin, Faure, Mathias, Boschetti, Gilles, Gay, Claire, Milot, Laurent, Roblin, Xavier

“…Cross-sectional magnetic resonance enterography (MRE) and intestinal ultrasonography (IUS) provide valuable and noninvasive information to accurately assess…”
Get full text

Association Between Low Trough Levels of Vedolizumab During Induction Therapy for Inflammatory Bowel Diseases and Need for Additional Doses Within 6 Months by Williet, Nicolas, Boschetti, Gilles, Fovet, Marion, Di Bernado, Thomas, Claudez, Pierre, Del Tedesco, Emilie, Jarlot, Camille, Rinaldi, Leslie, Berger, Anne, Phelip, Jean-Marc, Flourie, Bernard, Nancey, Stéphane, Paul, Stéphane, Roblin, Xavier

“…Background & Aims We investigated whether serum trough levels of vedolizumab, a humanized monoclonal antibody against integrin α4β7, during the induction phase…”
Get full text

Postoperative Endoscopic Recurrence on the Neoterminal Ileum But Not on the Anastomosis Is Mainly Driving Long-Term Outcomes in Crohn's Disease by Hammoudi, Nassim, Auzolle, Claire, Tran Minh, My-Linh, Boschetti, Gilles, Bezault, Madeleine, Buisson, Anthony, Pariente, Benjamin, Treton, Xavier, Seksik, Philippe, Fumery, Mathurin, Le Bourhis, Lionel, Nancey, Stéphane, Allez, Matthieu

“…Early ileocolonoscopy within the first year after surgery is the gold standard to evaluate recurrence after ileocolonic resection for Crohn's disease (CD). The…”
Get full text

No Difference of Adalimumab Pharmacokinetics When Dosed at 40 mg Every Week or 80 mg Every Other Week in IBD Patients in Clinical Remission After Adalimumab Dose Intensification by Paul, Stephane, Williet, Nicolas, Nancey, Stéphane, Veyrard, Pauline, Boschetti, Gilles, Phelip, Jean-Marc, Flourie, Bernard, Roblin, Xavier

“…Introduction The pharmacokinetic equivalence of dose intensification with adalimumab (ADA) 80 mg every other week (EOW) compared to weekly 40 mg has only been…”
Get full text

Effectiveness of golimumab intensification in ulcerative colitis: A multicentric prospective study by Fumery, Mathurin, Nancey, Stéphane, Filippi, Jérôme, Altwegg, Romain, Hébuterne, Xavier, Boshetti, Gilles, Barraud, Mathilde, Meynier, Jonathan, Paul, Stéphane, Roblin, Xavier

“…Summary Introduction Loss of response to golimumab occurs in nearly 40% of patients with ulcerative colitis (UC). Unlike others anti‐TNF, no study has reported…”
Get full text

The Kynurenine Pathway and Cancer: Why Keep It Simple When You Can Make It Complicated by Gouasmi, Roumaïssa, Ferraro-Peyret, Carole, Nancey, Stéphane, Coste, Isabelle, Renno, Toufic, Chaveroux, Cédric, Aznar, Nicolas, Ansieau, Stéphane

“…The kynurenine pathway has been highlighted as a gatekeeper of immune-privileged sites through its ability to generate from tryptophan a set of…”
Get full text

Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease by Buisson, Anthony, Gonzalez, Florent, Poullenot, Florian, Nancey, Stéphane, Sollellis, Elisa, Fumery, Mathurin, Pariente, Benjamin, Flamant, Mathurin, Trang-Poisson, Caroline, Bonnaud, Guillaume, Mathieu, Stéphane, Thevenin, Alain, Duruy, Marc, Filippi, Jérôme, Lʼhopital, François, Luneau, Fabrice, Michalet, Véronique, Genès, Julien, Achim, Anca, Cruzille, Emmanuelle, Bommelaer, Gilles, Laharie, David, Peyrin-Biroulet, Laurent, Pereira, Bruno, Nachury, Maria, Bouguen, Guillaume

“…Objective control of intestinal inflammation during inflammatory bowel disease (IBD) is becoming the main driver for medical treatment. However, the monitoring…”
Get full text

Concentrations of Ustekinumab During Induction Therapy Associate With Remission in Patients With Crohn’s Disease by Soufflet, Ninon, Boschetti, Gilles, Roblin, Xavier, Cuercq, Charlotte, Williet, Nicolas, Charlois, Anne-Laure, Duclaux-Loras, Remi, Danion, Pauline, Mialon, Anne, Faure, Mathias, Paul, Stéphane, Flourie, Bernard, Nancey, Stéphane

“…Ustekinumab is approved for treatment of Crohn’s disease (CD).1,2 Few data are available to assess the usefulness of monitoring inflammatory biomarkers and…”
Get full text

Physical Activity and IBD: State of Art and Knowledge, Patients and Healthcare Professionals Points of View, A French Multicenter Cross Sectional Study by Derbey, Lea, Charlois, Anne Laure, Buisson, Anthony, Roblin, Xavier, Mathieu, Nicolas, Danion, Pauline, Gay, Claire, Nancey, Stéphane, Boschetti, Gilles

“…Several studies have reported low levels of physical activity (PA) in patients with inflammatory bowel diseases (IBD), possibly related to a lack of…”
Get full text

Postoperative Endoscopic Recurrence on the Neoterminal Ileum But Not on the Anastomosis Is Mainly Driving Long-Term Outcomes in Crohn's Disease by Hammoudi, Nassim, Auzolle, Claire, Tran Minh, My-Linh, Boschetti, Gilles, Bezault, Madeleine, Buisson, Anthony, Pariente, Benjamin, Treton, Xavier, Seksik, Philippe, Fumery, Mathurin, Le Bourhis, Lionel, Nancey, Stéphane, Allez, Matthieu

“…Early ileocolonoscopy within the first year after surgery is the gold standard to evaluate recurrence after ileocolonic resection for Crohn's disease (CD). The…”
Get full text

Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial by Bommelaer, Gilles, Laharie, David, Nancey, Stéphane, Hebuterne, Xavier, Roblin, Xavier, Nachury, Maria, Peyrin-Biroulet, Laurent, Fumery, Mathurin, Richard, Damien, Pereira, Bruno, Goutte, Marion, Buisson, Anthony

“…AbstractBackground and aimsRecurrence of Crohn’s disease (CD) after surgery is a major concern. Curcumin has anti-inflammatory properties and induces…”
Get full text

Higher Serum Infliximab Concentrations Following Subcutaneous Dosing are Associated with Deep Remission in Patients with Inflammatory Bowel Disease by Roblin, Xavier, Nancey, Stéphane, Papamichael, Konstantinos, Duru, Gérard, Flamand, Mathurin, Kwiatek, Sandy, Cheifetz, Adam, Fabien, Nicole, Barrau, Mathilde, Paul, Stéphane

“…The relationship between subcutaneous infliximab [SC-IFX] concentrations and favourable therapeutic outcomes in patients with Crohn's disease [CD] and…”
Get full text

Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti‐TNF or conventional therapy: results of the European CONCEIVE study by Moens, Annick, Woude, C. Janneke, Julsgaard, Mette, Humblet, Evelien, Sheridan, Juliette, Baumgart, Daniel C., Gilletta De Saint‐Joseph, Cyrielle, Nancey, Stéphane, Rahier, Jean‐François, Bossuyt, Peter, Cremer, Anneline, Dewit, Sophie, Eriksson, Carl, Hoentjen, Frank, Krause, Thomas, Louis, Edouard, Macken, Elisabeth, Milenkovic, Zoran, Nijs, Jochen, Posen, Annelies, Van Hootegem, Anneleen, Van Moerkercke, Wouter, Vermeire, Séverine, Bar‐Gil Shitrit, Ariella, Ferrante, Marc

“…Summary Background Women with inflammatory bowel diseases (IBD) often receive biologicals during pregnancy to maintain disease remission. Data on outcome of…”
Get full text

Impaired reprogramming of the autophagy flux in maturing dendritic cells from crohn disease patients with core autophagy gene-related polymorphisms by Quiniou, Gaëlle, Andromaque, Leslie, Duclaux-Loras, Rémi, Dinet, Océane, Cervantes, Ornella, Verdet, Mallorie, Meunier, Camille, Boschetti, Gilles, Viret, Christophe, Nancey, Stéphane, Faure, Mathias, Rozières, Aurore

“…Crohn disease (CD) is an inflammatory bowel disease whose pathogenesis involves inappropriate immune responses toward gut microbiota on genetically predisposed…”
Get full text